GLP1 and GIP receptor agonists: effects on the gastrointestinal tract and management strategies for primary care physicians
Both HRS-9531 and MET-097 I think have a chance to help break the duopoly into smaller pieces, but itll still take until probably 2027 at the absolute earliest to see this happen and even then itll be a drug not featured during this conference
Kitada M, Ogura Y, Suzuki T, Sen S, Lee SM, Kanasaki K, et al
Hausenloy DJ, Yellon DM
It Deeply Unclogs Pores, Detoxify, Lighten &
Moreover, because GLP-1 drugs often rely on specific modifications to extend half-life or alter receptor binding, analytical studies must also confirm the integrity and consistency of these engineered features